Skip to main content

IMpower133: Atezolizumab plus standard chemotherapy boosted survival in ES-SCLC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
IMpower133: Atezolizumab plus standard chemotherapy boosted survival in ES-SCLC

User login

Username

Password

Reset your password

Type	Lead	score